Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents
International Journal of Diabetes in Developing Countries · 28.04.2026
DOI: 10.1007/s13410-026-01666-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Diabetes in Developing Countries, online erschienen am 28.04.2026. Verfasst von Ipseeta Ray Mohanty und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Mohanty, I. R., Ganguly, S., & Rai, S. (2026). Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents. International Journal of Diabetes in Developing Countries. https://doi.org/10.1007/s13410-026-01666-3
Vancouver
Mohanty IR, Ganguly S, Rai S. Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents. International Journal of Diabetes in Developing Countries. 2026. doi:10.1007/s13410-026-01666-3
BibTeX
@article{Mohanty2026,
author = {Mohanty, Ipseeta Ray and Ganguly, Shouvik and Rai, Sandeep},
title = {Pharmacogenetic insights into SLC22A1 and SLC22A2 polymorphisms affecting glycemic response to oral hypoglycemic agents},
journal = {International Journal of Diabetes in Developing Countries},
year = {2026},
doi = {10.1007/s13410-026-01666-3}
}
EUVIMED